D E C I S I O N 1. The concentration, which shall be acquired in the market of specialised (generic) pharmaceutical products in Bosnia and Herzegovina as result of the acquisition of the majority of shares of PLIVA D.D., Zagreb, Ulica grada Vukovara 49, Republic of Croatia by Bar Laboratories Europe B.V.i.o., Amsterdam, Rokin 55, Holland in the public bidding, is declared compatible.